Weight decreased
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
271
|
3
|
0.100 |
None |
|
0 |
|
|
|
Waist-Hip Ratio
|
phenotype |
|
Organism Attribute
|
565
|
1138
|
0.100 |
None |
1.000 |
3 |
3
|
2018 |
2019 |
Vertigo
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Sign or Symptom
|
173
|
35
|
0.100 |
None |
|
0 |
|
|
|
Ventricular arrhythmia
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
176
|
37
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Venous Thrombosis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
117
|
218
|
0.100 |
None |
|
0 |
|
|
|
Vascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
688
|
40
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Undifferentiated leukemia
|
disease |
|
Neoplastic Process
|
120
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Undifferentiated carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
283
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Ulcerative Colitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1458
|
827
|
0.100 |
None |
1.000 |
1 |
2
|
2015 |
2015 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2015 |
Tumor Immunity
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
337
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.050 |
None |
1.000 |
5 |
|
2017 |
2018 |
Tremor
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
528
|
52
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Transient Ischemic Attack
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
344
|
16
|
0.100 |
None |
|
0 |
|
|
|
Transformation to acute myeloid leukaemia
|
disease |
Neoplasms
|
Neoplastic Process
|
16
|
|
0.020 |
None |
0.500 |
2 |
|
2010 |
2013 |
Tinnitus
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
103
|
14
|
0.100 |
None |
|
0 |
|
|
|
Thymoma
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
291
|
20
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Thymic Carcinoma
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
82
|
8
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2017 |
Thrombocytosis
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
93
|
12
|
0.100 |
None |
|
0 |
|
|
|
Thrombocytopenia
|
phenotype |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
592
|
110
|
0.100 |
None |
|
0 |
|
|
|
Thrombocythemia, Essential
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
220
|
37
|
0.360 |
None |
1.000 |
8 |
|
2009 |
2016 |
Therapy-related myelodysplastic syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
42
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
T-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
485
|
24
|
0.060 |
None |
1.000 |
6 |
|
2012 |
2019 |
T-Cell and NK-Cell Neoplasm
|
disease |
|
Neoplastic Process
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
4
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |